Your browser doesn't support javascript.
loading
Phenotypic diversity among juvenile polyposis syndrome patients from different ethnic background.
Katz, Lior Haim; Gingold-Belfer, Rachel; Vainer, Elez; Hegger, Shani; Laish, Ido; Derazne, Estela; Weintraub, Ilana; Reznick-Levi, Gili; Goldberg, Yael; Levi, Zohar; Cohen, Shlomi; Half, Elizabeth E.
Afiliação
  • Katz LH; Department of Gastroenterology and Hepatology, Hadassah-Hebrew University Medical Center, Ein Kerem, 91120, Jerusalem, Israel. Liorkatz5346@gmail.com.
  • Gingold-Belfer R; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Liorkatz5346@gmail.com.
  • Vainer E; Division of Gastroenterology, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.
  • Hegger S; Sackler Faculty of Medicine, Tel Aviv University, 6997801, Tel Aviv, Israel.
  • Laish I; Department of Gastroenterology and Hepatology, Hadassah-Hebrew University Medical Center, Ein Kerem, 91120, Jerusalem, Israel.
  • Derazne E; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Weintraub I; Department of Internal Medicine B, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel.
  • Reznick-Levi G; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Goldberg Y; Department of Gastroenterology , Sheba Medical Center, Tel-Hashomer, Israel.
  • Levi Z; Statistic Department, The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Cohen S; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
  • Half EE; Genetics Department, RAMBAM Health Care Campus, Haifa, Israel.
Hered Cancer Clin Pract ; 20(1): 2, 2022 Jan 20.
Article em En | MEDLINE | ID: mdl-35057835
ABSTRACT
Juvenile polyposis syndrome (JPS), has diverse phenotypes.

AIM:

To assess mutation rate, clinical features and genotype-phenotype correlation among Israeli JPS kindreds from different ethnicities.

METHODS:

Patients' data were extracted retrospectively from 5 centers.

RESULTS:

Thirty five kindreds (49 patients) were included. Thirty one (89%) Jewish [10 (32%) Ashkenazi; 9 (29%) Sephardi; 11 (35%) non-Russia former Soviet-Union countries (NRFSU), one (3%) unknown]. 40/49 individuals from 27 families underwent genetic testing. Among them 34, from 21 families (85, 78%, respectively) had a pathogenic mutation BMPR1A n = 15 (71%), SMAD4 n = 6 families (29%). While no SMAD4 mutation was described among Jewish families from NRFSU, 7 NRFSU families carried a founder mutation comprising a large genomic deletion of BMPR1A. GI involvement was reported in 42 patients (86%) colonic polyps (n = 40, 95%, > 50 polyps n = 14, 35%) and 12 underwent colonic resection. Fourteen patients (34%) had gastric or small bowel involvement (n = 5) and 4\14 underwent gastrectomy due to polyp burden. Families from NRFSU had more gastric involvement (66.7% vs. 22.2%- Sephardic and 20%- Ashkenazi Jews; p = 0.038), with more gastric polyps (p = 0.017).

CONCLUSIONS:

We demonstrated a high rate of mutation detection in the heterogeneous population of Israel. Patients from NRFSU with BMPR1A mutation had high rate of gastric involvement.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article